SCPHARMACEUTICALS INC. Capital Expenditures
SCPHARMACEUTICALS INC. reported Capital Expenditures of $21.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-03-19
- SCPHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $12.00K, a 67.57% decline year-over-year.
- SCPHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $37.00K.
- SCPHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- SCPHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $0.00.
- SCPHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $21.00K, a 47.50% decline from fiscal 2023.
- SCPHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2023 was $40.00K, a 90.48% increase from fiscal 2022.
- SCPHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2022 was $21.00K, a 133.33% increase from fiscal 2021.
- SCPHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2021 was $9.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $21.00K 10-K · filed 2025-03-19 | ||
| 2024-09-30 | $9.00K 10-Q · filed 2024-11-13 | |||
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $37.00K derived: sum of 2 quarters · filed 2025-03-19 | $40.00K 10-K · filed 2025-03-19 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $3.00K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $15.00K derived: sum of 2 quarters · filed 2024-03-13 | $15.00K derived: sum of 3 quarters · filed 2024-03-13 | $21.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $15.00K derived: sum of 2 quarters · filed 2023-11-08 | $21.00K 10-Q · filed 2023-11-08 | $20.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $6.00K 10-Q · filed 2023-08-10 | $5.00K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $6.00K 10-Q · filed 2023-05-10 | $5.00K derived: sum of 2 quarters · filed 2023-05-10 | ||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $9.00K 10-K · filed 2023-03-22 | ||
| 2021-09-30 | $10.00K 10-Q · filed 2022-11-09 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $41.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $41.00K 10-Q · filed 2019-08-07 | |||
| 2017-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21 | $182.00K derived: sum of 2 quarters · filed 2019-03-21 | $194.00K 10-K · filed 2019-03-21 | |
| 2017-09-30 | $178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $190.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $12.00K 10-Q · filed 2018-08-14 | |||
| 2016-12-31 | $9.00K 10-K · filed 2019-03-21 |